ResearcherGeorgetown University Medical CenterNo recent work listed

Reetu Mukherji

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7384-0498; OpenAlex author ID A5031352538. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

Prognostic utility of preoperative and postoperative KRAS-mutated circulating tumor DNA (ctDNA) in resected pancreatic ductal adenocarcinoma: A systematic revi… Co-author DOI 10.1016/j.suronc.2023.102007 ↗
The Role of Immunotherapy in Pancreatic Cancer. Co-author DOI 10.3390/curroncol29100541 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Marion L. Hartley · 1 shared paper, 2022 · strength 0.22
- Paper The Role of Immunotherapy in Pancreatic Cancer. DOI 10.3390/curroncol29100541 ↗
Marcus Smith Noel · 1 shared paper, 2022 · strength 0.22
- Paper The Role of Immunotherapy in Pancreatic Cancer. DOI 10.3390/curroncol29100541 ↗
Ali Jaber Alqahtani · 1 shared paper, 2023 · strength 0.22
- Paper Prognostic utility of preoperative and postoperative KRAS-mutated circulating tumor DNA (ctDNA) in resected pancreatic … DOI 10.1016/j.suronc.2023.102007 ↗
Chao Yin · 1 shared paper, 2023 · strength 0.22
- Paper Prognostic utility of preoperative and postoperative KRAS-mutated circulating tumor DNA (ctDNA) in resected pancreatic … DOI 10.1016/j.suronc.2023.102007 ↗
Benjamin Adam Weinberg · 1 shared paper, 2023 · strength 0.22
- Paper Prognostic utility of preoperative and postoperative KRAS-mutated circulating tumor DNA (ctDNA) in resected pancreatic … DOI 10.1016/j.suronc.2023.102007 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.